相关实验视频
Updated: Jun 18, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
在晚期黑色素瘤的免疫疗法治疗中生存的预测因素:元分析
Daishi Li1,2,3,4,5,6, Yuming Sun7, Jiayuan Le1,2,3,4,5,6
1Central South University, Changsha, China.
International journal of dermatology
|August 4, 2024
概括
免疫疗法显著改善了晚期黑色素瘤患者的生存率. 某些患者特征有助于预测对双重免疫疗法或化学免疫疗法的反应,指导治疗选择以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 黑色素瘤研究 黑色素瘤研究
背景情况:
- 免疫疗法已经改变了晚期黑色素瘤的治疗方法,但并非所有患者都受益.
- 预测性生物标志物对于优化免疫疗法选择和改善患者治疗结果至关重要.
研究的目的:
- 系统地评估双重免疫疗法和化疗免疫疗法与对照治疗在晚期黑色素瘤中的疗效.
- 确定临床病理学和分子特征,预测患者对不同免疫疗法策略的反应.
主要方法:
- 19项随机对照试验的系统综述和元分析,涉及13,809名晚期黑色素瘤患者.
- 基于治疗手臂和患者子组的总生存率 (OS) 和无复发生存率 (RFS) 的分析.
- 使用R版本4.3.0.0进行的统计分析.
主要成果:
- 与对照组相比,免疫疗法策略 (单一或组合) 显著改善了OS和RFS.
- 单免疫疗法有利于PD-L1阳性患者,AJCCIIIC阶段,以及具有≥4阳性淋巴结的患者与化疗相比.
- 联合免疫疗法改善了65岁以下的患者的OS和RFS,ECOG状态为0和正常的LDH水平,而不是单一治疗.
结论:
- 基于免疫治疗的策略在晚期黑色素瘤中提供了显著的生存益处.
- 特定的患者特征,包括PD-L1状态,AJCC阶段,淋巴结状态,年龄,ECOG性能状态和LDH水平,可以指导选择最佳免疫疗法方法.
相关概念视频
Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K

